Lopez-Hernandez, Daniel and Beltran-Lagunes, Luis and Soto-de-la-Cruz, Pilar and Brito-Aranda, Leticia and Pavon-Delgado, Ernestina and Castro-Diaz, Alaina Mariana and Melgarejo-Estefan, Emmanuel and Orozco-Campos, Nadhyieli and Vazquez-Sanchez, Alberto and Torres-Garcia, Edgar Esteban and Garcia-Edgar, Victor Noe and Duran-Rojo, Roberto and Olivares-Lopez, Xochitl Liliana and Noguez-Alvarez, Victor Hugo and Anguiano-Velazquez, Tabata Gabriela and Nuñez-Calvillo, Miguel Angel and Herrerias-Colin, Luis Angel and Granados-Kraulles, Jorge Arturo and Sanchez-Barcernas, Ricardo Alejandro and Santiago-Sanchez, Benita and Juarez-Montoya, Carmen Lizzete and Ramirez, Israel Ambrosio and Miranda, Miriam Idalith Infante (2024) Associated Factors of Polypharmacy among Elderly Patients Attended at Primary Care Setting. Current Journal of Applied Science and Technology, 43 (8). pp. 73-87. ISSN 2457-1024
Hernandez4382024CJAST121375.pdf - Published Version
Download (412kB)
Abstract
Aims: To determine the factors associated with polypharmacy in individuals aged 60 and over attending at a primary care unit.
Methodology: A case-control study was designed with the population served from January 2017 to December 2018 at the “Aragón” Family Medicine Clinic.
Results: A total population of 1,657 cases and 1,657 controls was included. The prevalence of excessive polypharmacy was significantly higher (p < 0.001) among patients seen in the MIDE module (n=203, 59.2%; 95% CI 54.2-65.0) and Dentistry (n=188, 48.1%; 95% CI 43.0-52.9). The most frequently prescribed and dispensed medications were nonsteroidal anti-inflammatory drugs, proton pump inhibitors, vitamins, statins, lipid-lowering agents, and non-insulin hypoglycemic agents. A significant association was observed between polypharmacy and the number of services used (OR=2.87; 95% CI 2.40-3.43, p< 0.001 for 2 services, and OR=11.21; 95% CI 6.28-20.03, p< 0.001 for 3 or more services), the presence of multiple morbidities (OR=5.65; 95% CI 4.73-6.76, p< 0.001), and the type of entitlement (OR=0.80; 95% CI 0.69-0.94, p=0.009; family members).
Conclusions: The risk factors associated with polypharmacy are linked to the clinical conditions of the patient and the medicalisation process of primary care.
Item Type: | Article |
---|---|
Subjects: | STM Open Academic > Multidisciplinary |
Depositing User: | Unnamed user with email admin@eprint.stmopenacademic.com |
Date Deposited: | 20 Aug 2024 05:53 |
Last Modified: | 20 Aug 2024 05:53 |
URI: | http://publish.sub7journal.com/id/eprint/2245 |